Skip to NavigationSkip to content

OPEN Health reveals new CEO appointment

Published on 19/11/20 at 12:55pm

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN Health, replacing current CEO and Co-Founder David Rowley, who has been in the role for a decade.

Barker steps into the head role after six years at the company, having most recently served as CEO of Open Health’s Medical Communications practice. Over the course of his 30-year career in biopharmaceuticals, Barker has held a number of executive leadership roles at companies including Huntsworth Health, The Central Group and Medicus International.

“Medical affairs, medical communications, market Access and health economics and outcomes research (HEOR) have taken on increasingly important roles in bringing new therapies to market,” said Nick Amigone, a partner at Amulet Capital, OPEN Health’s parent company. “Rob has been instrumental in assembling a suite of best-in-class capabilities at OPEN Health and driving the business to achieve its full potential.”

Barker voiced his enthusiasm for the new role: “I am excited to be leading such a talented and expert team who have been instrumental in growing OPEN Health to its current position. We are now in a place to take even greater strides forward, and I feel confident that our continued focus on client service and scientific excellence will drive increased growth in the business.”

Matt Fellows

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches